关注
Gen Yamada
Gen Yamada
Disease Control and Prevention Center, National Center for Global Health and Medicine
在 hosp.ncgm.go.jp 的电子邮件经过验证
标题
引用次数
引用次数
年份
Predicting respiratory failure for COVID-19 patients in Japan: a simple clinical score for evaluating the need for hospitalisation
G Yamada, K Hayakawa, N Matsunaga, M Terada, S Suzuki, Y Asai, ...
Epidemiology & Infection 149, e175, 2021
222021
Utility of the antigen test for coronavirus disease 2019: factors influencing the prediction of the possibility of disease transmission
K Yamamoto, M Suzuki, G Yamada, T Sudo, H Nomoto, N Kinoshita, ...
International Journal of Infectious Diseases 104, 65-72, 2021
162021
Two cases of breakthrough SARS-CoV-2 infections caused by the Omicron variant (B. 1.1. 529 lineage) in international travelers to Japan
T Maruki, N Iwamoto, K Kanda, N Okumura, G Yamada, M Ishikane, ...
Clinical Infectious Diseases: An Official Publication of the Infectious …, 2022
152022
Impact of body weight gain on the incidence of nonalcoholic fatty liver disease in nonobese Japanese individuals
G Yamada, Y Hagiwara, T Kimura, Y Takeuchi, K Oba, K Masuda, ...
Official journal of the American College of Gastroenterology| ACG 116 (4 …, 2021
152021
Effectiveness of remdesivir in hospitalized nonsevere patients with COVID-19 in Japan: A large observational study using the COVID-19 Registry Japan
S Tsuzuki, K Hayakawa, Y Uemura, T Shinozaki, N Matsunaga, M Terada, ...
International Journal of Infectious Diseases 118, 119-125, 2022
142022
Multisystem inflammatory syndrome in adult after first dose of mRNA vaccine
Y Miyazato, K Yamamoto, G Yamada, S Kubota, M Ishikane, M Sugiyama, ...
Emerging infectious diseases 28 (4), 870, 2022
112022
Time-course evaluation of the quantitative antigen test for severe acute respiratory syndrome coronavirus 2: the potential contribution to alleviating isolation of COVID-19 …
H Nomoto, K Yamamoto, G Yamada, M Suzuki, N Kinoshita, J Takasaki, ...
Journal of Infection and Chemotherapy 27 (11), 1669-1673, 2021
102021
Diagnostic ability using fatty liver and metabolic markers for metabolic‐associated fatty liver disease stratified by metabolic/glycemic abnormalities
A Okada, G Yamada, T Kimura, Y Hagiwara, S Yamaguchi, KI Kurakawa, ...
Journal of Diabetes Investigation 14 (3), 463-478, 2023
82023
Interferon lambda 3 in the early phase of coronavirus disease‐19 can predict oxygen requirement
T Suzuki, N Iwamoto, S Tsuzuki, Y Kakumoto, M Suzuki, S Ashida, ...
European Journal of Clinical Investigation 52 (9), 2022
82022
Listeria monocytogenes ankle osteomyelitis in a patient with rheumatoid arthritis on adalimumab: a report and literature review of Listeria monocytogenes osteomyelitis
T Kubota, Y Mori, G Yamada, I Cammack, T Shinohara, S Matsuzaka, ...
Internal Medicine 60 (19), 3171-3176, 2021
62021
External validation and update of prediction models for unfavorable outcomes in hospitalized patients with COVID-19 in Japan
G Yamada, K Hayakawa, Y Asai, N Matsunaga, H Ohtsu, M Hojo, ...
Journal of Infection and Chemotherapy 27 (7), 1043-1050, 2021
62021
Clinical outcomes and epidemiological characteristics of bacteremia in the older Japanese population
K Nakamura, K Hayakawa, S Tsuzuki, S Ide, H Nomoto, T Nakamoto, ...
Journal of Infection and Chemotherapy 29 (10), 971-977, 2023
52023
Factors associated with high antibody titer following coronavirus disease among 581 convalescent plasma donors: a single-center cross-sectional study in Japan
T Suzuki, Y Asai, S Ide, S Fukuda, A Tanaka, Y Shimanishi, K Takahashi, ...
Journal of Infection and Chemotherapy 28 (2), 206-210, 2022
52022
Fatty liver on computed tomography scan on admission is a risk factor for severe coronavirus disease
A Okuhama, M Hotta, M Ishikane, A Kawashima, Y Miyazato, M Terada, ...
Journal of Infection and Chemotherapy 28 (2), 217-223, 2022
52022
Predictive model of risk factors of High Flow Nasal Cannula using machine learning in COVID-19
N Matsunaga, K Kamata, Y Asai, S Tsuzuki, Y Sakamoto, S Ijichi, ...
Infectious Disease Modelling 7 (3), 526-534, 2022
42022
Potential usage of anterior nasal sampling in clinical practice with three rapid antigen tests for SARS-CoV-2
H Nomoto, K Yamamoto, E Isaka, Y Miyazato, T Suzuki, T Maruki, ...
Journal of Infection and Chemotherapy 29 (1), 15-19, 2023
22023
Effectiveness of oral cephalexin in antibiotic-course completion for methicillin-susceptible Staphylococcus aureus-induced bacteremic vertebral osteomyelitis
N Okumura, K Hayakawa, K Yamamoto, G Yamada, K Mezaki, ...
BMC Infectious Diseases 23 (1), 307, 2023
12023
Methodological concerns regarding a retrospective study with real-world data on Paxlovid in Israel
S Uchikoba, G Yamada, S Tsuzuki
Clinical Infectious Diseases 75 (12), 2278-2279, 2022
12022
Systemic corticosteroid as an adjunctive treatment for lower respiratory tract infection in children with severe motor and intellectual disabilities
T Nakamoto, T Hoshina, M Ishii, G Yamada, K Kusuhara
Journal of Infection and Chemotherapy 28 (3), 384-388, 2022
12022
Pulmonary histoplasmosis diagnosed in a Japanese woman after traveling to central and South America: A case report
S Ide, S Kutsuna, G Yamada, K Hashimoto, M Abe, M Nagi, M Ujiie, ...
Journal of Infection and Chemotherapy 27 (11), 1658-1661, 2021
12021
系统目前无法执行此操作,请稍后再试。
文章 1–20